Sven-Erik Dahlén and Anita Sydbom
Mast cells, nerves and IgE
John Bienenstock (Canada)
Post-consolidation therapy with histamine dihydrochloride and interleukin-2 in acute myelogenous leukemia.
Kristoffer Hellstrand (Sweden)
The vertebrate brain histaminergic system: a multifaceted network.
Pertti Panula (Finland)
Differential release of mast cell mediators – implications in health and disease.
Gunnar Nilsson (Sweden)
The role of serglycin proteoglycan in mast cell secretory granule formation
Gunnar Pejler (Sweden)
Intracellular trafficking and signaling mechanisms in the secretion of inflammatory mediators and histamine by mast cells.
Ulrich Blank (France)